Skip to contentW
West Pharmaceutical Services Inc
W
WSTWest Pharmaceutical Services Inc Source filing unavailable
Q4 2011 · —
derived · Computed from the longer spans the company filed.
Revenue$295.40M$295.40Mderived+6.7% vs Q4 2010 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
+0.6% vs Q3 2011
Net Income$18.90M$18.90Mderived+215.0% vs Q4 2010+11.8% vs Q3 2011 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$85,300,000+9.4% Operating Incomederived$26,900,000+348.3% Operating Cash Flowderived$41,800,000−11.4% Free Cash Flowderived$8,400,000−67.6% Margins · derivedGross margin28.9%+0.7 pt vs Q4 2010
Operating margin9.1%+6.9 pt vs Q4 2010
Net margin6.4%+4.2 pt vs Q4 2010